| Depression |
1 |
1 |
| Child |
0 |
0.99 |
| Cognitive Behavioral Therapy |
0 |
0.45 |
| Referral |
0 |
0.42 |
| Adolescent Medicine |
0 |
0.98 |
| Anxiety |
0 |
0.28 |
| Psychotherapy |
0 |
0.28 |
| Evidence-Based Psychotherapy |
0 |
0.25 |
| Anxiety Disorder |
0 |
0.18 |
| Adverse Effects |
0 |
0.14 |
| Antidepressant drug |
0 |
0.14 |
| Mania |
0 |
0.14 |
| Meta-Analysis |
0 |
0.14 |
| Primary Care |
0 |
0.14 |
| Refractory |
0 |
0.14 |
| Remission |
0 |
0.14 |
| Suicide |
0 |
0.14 |
| Patient Safety |
0 |
0.09 |
| Adherence |
0 |
0.07 |
| Agitation |
0 |
0.07 |
| Antipsychotics |
0 |
0.07 |
| Behavioral Modification Therapy |
0 |
0.07 |
| Clinical Guidelines |
0 |
0.07 |
| Diagnostic and Statistical Manual of Mental Disorders |
0 |
0.07 |
| Electroconvulsive Therapy |
0 |
0.07 |
| Exercise |
0 |
0.07 |
| Fatty Acids |
0 |
0.07 |
| Food and Drug Administration (FDA) |
0 |
0.07 |
| Genetics |
0 |
0.07 |
| Insomnia |
0 |
0.07 |
| LGBT |
0 |
0.07 |
| Major Depression |
0 |
0.97 |
| Malnutrition |
0 |
0.07 |
| Preventive Screening |
0 |
0.07 |
| Prognosis |
0 |
0.07 |
| Repetitive Transcranial Magnetic Stimulation |
0 |
0.07 |
| Selective Serotonin-Reuptake Inhibitors |
0 |
0.07 |
| Serotonin Syndrome |
0 |
0.07 |
| Sexual Dysfunction |
0 |
0.07 |
| Sleep |
0 |
0.07 |
| Complementary and Alternative Medicine |
0 |
0.05 |
| Eating Disorders |
0 |
0.05 |
| Genomic Medicine |
0 |
0.05 |
| Headache |
0 |
0.05 |
| Hypothyroidism |
0 |
0.05 |
| Sleep Disorders |
0 |
0.05 |
| Social Determinants of Health |
0 |
0.05 |
| Thyroid Disease |
0 |
0.05 |